Abivax price target lowered to $118 from $140 at Wedbush
Downgrade with reduced upside; risk-off bias.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Downgrade with reduced upside; risk-off bias.
What happened, with direct paths to the underlying reporting
Wedbush reduces ABVX target to 118; price 103.45; signals downside risk.
Target: $118
Posted price: $103.45
Analyst firm: Wedbush
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.